I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Piasecka-Stryczynska, Karolina
16
results:
Online X
Search for persons
X
Format
Online (16)
Mediatypes
Articles (Online) (11)
OpenAccess-fulltext (5)
Languages
english (14)
french (1)
Sorted by: Relevance
Sorted by: Year
?
1
Efficacy and safety results after >3.5 years of treatment w..:
Montalban, Xavier
;
Piasecka-Stryczynska, Karolina
;
Kuhle, Jens
...
Multiple Sclerosis Journal. 30 (2024) 4-5 - p. 558-570 , 2024
Link:
https://doi.org/10.1177/..
?
2
Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibit..:
Montalban, Xavier
;
Wolinsky, Jerry S.
;
Arnold, Douglas L.
...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023
Link:
https://doi.org/10.1212/..
?
3
Update on Long-Term Efficacy and Safety of Evobrutinib, a B..:
Montalban, Xavier
;
Wolinsky, Jerry S.
;
Arnold, Douglas L.
...
Multiple Sclerosis and Related Disorders. 80 (2023) - p. 105329 , 2023
Link:
https://doi.org/10.1016/..
?
4
Safety and Efficacy of Evobrutinib, a Bruton's Tyrosine Kin..:
Montalban, Xavier
;
Wolinsky, Jerry S.
;
Arnold, Douglas L.
...
Neurology. 98 (2022) 18_supplement - p. , 2022
Link:
https://doi.org/10.1212/..
?
5
Safety of Evobrutinib in Patients With Relapsing Multiple S..:
Montalban, Xavier
;
Arnold, Douglas L.
;
Weber, Martin S.
...
Neurology. 96 (2021) 15_supplement - p. , 2021
Link:
https://doi.org/10.1212/..
?
6
Concentration of evobrutinib, a BTK inhibitor, in cerebrosp..:
Piasecka-Stryczynska, Karolina
;
Rejdak, Konrad
;
Dyroff, Martin
...
Multiple Sclerosis and Related Disorders. 51 (2021) - p. 103001 , 2021
Link:
https://doi.org/10.1016/..
?
7
Taux de poussées chez les patients atteints de SEP rémitten..:
Montalban, Xavier
;
Arnold, Douglas
;
Weber, Martin S.
...
Revue Neurologique. 177 (2021) - p. S123 , 2021
Link:
https://doi.org/10.1016/..
?
8
Evobrutinib Efficacy is Maintained Over Two Years in an Ope..:
Montalban, Xavier
;
Arnold, Douglas L.
;
Weber, Martin S.
...
Neurology. 96 (2021) 15_supplement - p. , 2021
Link:
https://doi.org/10.1212/..
?
9
Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibit..:
Montalban, Xavier
;
Arnold, Douglas L
;
Weber, Martin S
...
Multiple Sclerosis and Related Disorders. 37 (2020) - p. 101603 , 2020
Link:
https://doi.org/10.1016/..
?
10
Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibit..:
Montalban, Xavier
;
Arnold, Douglas L.
;
Weber, Martin S.
...
Neurology. 92 (2019) 15_supplement - p. , 2019
Link:
https://doi.org/10.1212/..
?
11
"Positive Regulation of RNA Metabolic Process" Ontology Gro..:
Celichowski, Piotr
;
Nawrocki, Mariusz J.
;
Dyszkiewicz-Konwińska, Marta
...
BioMed Research International. 2018 (2018) - p. 1-10 , 2018
Link:
https://doi.org/10.1155/..
?
12
Efficacy and safety results after >3.5 years of treatment w..:
Montalban, Xavier
;
Piasecka-Stryczynska, Karolina
;
Kuhle, Jens
...
https://resolver.sub.uni-goettingen.de/purl?gro-2/142683. , 2024
Link:
https://resolver.sub.uni..
?
13
Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibit..:
Montalban, Xavier
;
Wolinsky, Jerry S
;
Arnold, Douglas L
...
https://resolver.sub.uni-goettingen.de/purl?gro-2/138645. , 2023
Link:
https://resolver.sub.uni..
?
14
Placebo-controlled trial of an oral BTK inhibitor in multip..:
Montalban Gairín, Xavier
;
Douglas, Arnold L
;
Martin, Weber S
...
New England Journal of Medicine;380(25). , 2019
Link:
https://hdl.handle.net/1..
?
15
Placebo-Controlled Trial of an Oral BTK Inhibitor in Multip..:
Montalban, Xavier
;
Arnold, Douglas L
;
Weber, Martin S
...
https://resolver.sub.uni-goettingen.de/purl?gro-2/134326. , 2019
Link:
https://resolver.sub.uni..
1-15